U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C18H22N2
Molecular Weight 266.3807
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CYCLIZINE

SMILES

CN1CCN(CC1)C(C2=CC=CC=C2)C3=CC=CC=C3

InChI

InChIKey=UVKZSORBKUEBAZ-UHFFFAOYSA-N
InChI=1S/C18H22N2/c1-19-12-14-20(15-13-19)18(16-8-4-2-5-9-16)17-10-6-3-7-11-17/h2-11,18H,12-15H2,1H3

HIDE SMILES / InChI
Molecular Formula C18H22N2
Molecular Weight 266.3807
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Unknown
86413
Substance Class Chemical
Created
by admin
on Sat Dec 16 16:44:53 UTC 2023
Edited
by admin
on Sat Dec 16 16:44:53 UTC 2023
Record UNII
QRW9FCR9P2
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CYCLIZINE
HSDB   INN   MART.   MI   VANDF   WHO-DD  
INN  
Official Name English
CYCLIZINE [MART.]
Common Name English
CYCLIZINE [HSDB]
Common Name English
CYCLIZINE [MI]
Common Name English
1-(Diphenylmethyl)-4-methylpiperazine
Systematic Name English
cyclizine [INN]
Common Name English
CYCLIZINE [VANDF]
Common Name English
Cyclizine [WHO-DD]
Common Name English
PIPERAZINE, 1-(DIPHENYLMETHYL)-4-METHYL-
Systematic Name English
NSC-26608
Code English
Classification Tree Code System Code
WHO-ESSENTIAL MEDICINES LIST 8.4
Created by admin on Sat Dec 16 16:44:54 UTC 2023 , Edited by admin on Sat Dec 16 16:44:54 UTC 2023
WHO-ATC R06AE53
Created by admin on Sat Dec 16 16:44:54 UTC 2023 , Edited by admin on Sat Dec 16 16:44:54 UTC 2023
WHO-VATC QR06AE53
Created by admin on Sat Dec 16 16:44:54 UTC 2023 , Edited by admin on Sat Dec 16 16:44:54 UTC 2023
NCI_THESAURUS C267
Created by admin on Sat Dec 16 16:44:54 UTC 2023 , Edited by admin on Sat Dec 16 16:44:54 UTC 2023
WHO-ATC R06AE03
Created by admin on Sat Dec 16 16:44:54 UTC 2023 , Edited by admin on Sat Dec 16 16:44:54 UTC 2023
WHO-VATC QR06AE03
Created by admin on Sat Dec 16 16:44:54 UTC 2023 , Edited by admin on Sat Dec 16 16:44:54 UTC 2023
LIVERTOX 246
Created by admin on Sat Dec 16 16:44:54 UTC 2023 , Edited by admin on Sat Dec 16 16:44:54 UTC 2023
Code System Code Type Description
ECHA (EC/EINECS)
201-445-5
Created by admin on Sat Dec 16 16:44:54 UTC 2023 , Edited by admin on Sat Dec 16 16:44:54 UTC 2023
PRIMARY
WIKIPEDIA
CYCLIZINE
Created by admin on Sat Dec 16 16:44:54 UTC 2023 , Edited by admin on Sat Dec 16 16:44:54 UTC 2023
PRIMARY
HSDB
3309
Created by admin on Sat Dec 16 16:44:54 UTC 2023 , Edited by admin on Sat Dec 16 16:44:54 UTC 2023
PRIMARY
FDA UNII
QRW9FCR9P2
Created by admin on Sat Dec 16 16:44:54 UTC 2023 , Edited by admin on Sat Dec 16 16:44:54 UTC 2023
PRIMARY
LACTMED
Cyclizine
Created by admin on Sat Dec 16 16:44:54 UTC 2023 , Edited by admin on Sat Dec 16 16:44:54 UTC 2023
PRIMARY
CHEBI
3994
Created by admin on Sat Dec 16 16:44:54 UTC 2023 , Edited by admin on Sat Dec 16 16:44:54 UTC 2023
PRIMARY
INN
176
Created by admin on Sat Dec 16 16:44:54 UTC 2023 , Edited by admin on Sat Dec 16 16:44:54 UTC 2023
PRIMARY
DRUG BANK
DB01176
Created by admin on Sat Dec 16 16:44:54 UTC 2023 , Edited by admin on Sat Dec 16 16:44:54 UTC 2023
PRIMARY
NCI_THESAURUS
C65356
Created by admin on Sat Dec 16 16:44:54 UTC 2023 , Edited by admin on Sat Dec 16 16:44:54 UTC 2023
PRIMARY
RXCUI
2977
Created by admin on Sat Dec 16 16:44:54 UTC 2023 , Edited by admin on Sat Dec 16 16:44:54 UTC 2023
PRIMARY RxNorm
SMS_ID
100000083729
Created by admin on Sat Dec 16 16:44:54 UTC 2023 , Edited by admin on Sat Dec 16 16:44:54 UTC 2023
PRIMARY
ChEMBL
CHEMBL648
Created by admin on Sat Dec 16 16:44:54 UTC 2023 , Edited by admin on Sat Dec 16 16:44:54 UTC 2023
PRIMARY
MESH
D003501
Created by admin on Sat Dec 16 16:44:54 UTC 2023 , Edited by admin on Sat Dec 16 16:44:54 UTC 2023
PRIMARY
EPA CompTox
DTXSID4022864
Created by admin on Sat Dec 16 16:44:54 UTC 2023 , Edited by admin on Sat Dec 16 16:44:54 UTC 2023
PRIMARY
CAS
82-92-8
Created by admin on Sat Dec 16 16:44:54 UTC 2023 , Edited by admin on Sat Dec 16 16:44:54 UTC 2023
PRIMARY
DRUG CENTRAL
749
Created by admin on Sat Dec 16 16:44:54 UTC 2023 , Edited by admin on Sat Dec 16 16:44:54 UTC 2023
PRIMARY
NSC
26608
Created by admin on Sat Dec 16 16:44:54 UTC 2023 , Edited by admin on Sat Dec 16 16:44:54 UTC 2023
PRIMARY
IUPHAR
7151
Created by admin on Sat Dec 16 16:44:54 UTC 2023 , Edited by admin on Sat Dec 16 16:44:54 UTC 2023
PRIMARY
EVMPD
SUB06847MIG
Created by admin on Sat Dec 16 16:44:54 UTC 2023 , Edited by admin on Sat Dec 16 16:44:54 UTC 2023
PRIMARY
MERCK INDEX
m3973
Created by admin on Sat Dec 16 16:44:54 UTC 2023 , Edited by admin on Sat Dec 16 16:44:54 UTC 2023
PRIMARY Merck Index
PUBCHEM
6726
Created by admin on Sat Dec 16 16:44:54 UTC 2023 , Edited by admin on Sat Dec 16 16:44:54 UTC 2023
PRIMARY
Related Record Type Details
HISTAMINE H1 RECEPTOR
TARGET -> INHIBITOR
Structure of CYCLIZINE HYDROCHLORIDE
SALT/SOLVATE -> PARENT
Related Record Type Details
Structure of CYCLIZINE
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Volume of Distribution PHARMACOKINETIC
Biological Half-life PHARMACOKINETIC
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966